Latest filing published 11 Mar 2025 for Aquestive Therapeutics, Inc..
Insider track record
Stephen Wargacki: trading record in brief
Stephen Wargacki discloses dealings in Aquestive Therapeutics, Inc. to SEC (Form 4). We count 11 filings; the first trade dates from 9 March 2023 and the latest from 10 March 2025.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 11 March 2025 came the latest disclosure, a share grant for €32k in Aquestive Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Stephen Wargacki
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 115,000 shares0Common StockSEC:0001214659-25-004228:0
- 19,505 shares@ US$4.8863.4% of flowCommon StockSEC:0001214659-24-017010:0
- 10,000 shares0Common StockSEC:0001214659-24-008874:0
- 11,269 shares@ US$4.8836.6% of flowCommon StockSEC:0001214659-24-004391:0
- 1,981 shares@ US$0.79371.1% of flowCommon StockSEC:0001214659-24-004302:0
- 135,000 shares0Common StockSEC:0001214659-23-003689:0
6 of 6 declarations